Biotech news
Refine search
Americas
Strong IP knowledge is one of four key factors to succeeding in the burgeoning US biosimilars market, according to an industry report. 15 May 2013
Americas
The US Supreme Court has decided unanimously in favour of agricultural company Monsanto in its patent battle against Indiana farmer Vernon Bowman. 14 May 2013
Americas
Baker & McKenzie has hired Christian Alejandro López-Silva as head of its pharmaceutical and life sciences group in Mexico. 30 April 2013
Americas
Cyclacel Pharmaceuticals has entered into a definitive agreement to sell four of its patents related to the use of the romidepsin injection to Celgene Corporation. 30 April 2013
Americas
James Monroe and Lawrence Ilag of Finnegan, Henderson, Farabow, Garrett & Dunner LLP analyse the impact of the US Court of Appeals for the Federal Circuit’s decision In re Kubin. 30 April 2013
Americas
While the global trend is towards a “more hostile IP environment” for pharmaceutical companies, Danish healthcare giant Novo Nordisk A/S continues to perform. LSIPR talks to Lars Kellberg, corporate vice president, about how it meets the challenges. 30 April 2013
Americas
The US Patent and Trademark Office has announced the winners of its Patents for Humanity competition, which recognises patent owners and licensees addressing global health and development challenges. 12 April 2013
Asia
India’s patent office has published final guidelines for examining biotechnology patents, after accepting comments on a draft version published in December. 2 April 2013
Americas
Challenging the validity of a patent through the court systems of Europe and the US can be a time-consuming and expensive process. Jane Wainwright and Daniel Young look at the alternatives. 1 April 2013
Biotech
In its effort to tackle the threat of ‘evergreening’, the CJEU has caused some uncertainty about supplementary protection certificates, as Jaap Mannaerts explains. 1 April 2013